Alex N Bullock Selected Research

Tacrolimus Binding Protein 1A (FKBP12)

1/2021	ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex.
1/2018	Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alex N Bullock Research Topics

Disease

22	Neoplasms (Cancer) 01/2021 - 12/2005
14	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 06/2022 - 03/2011
7	Diffuse Intrinsic Pontine Glioma 01/2021 - 10/2014
7	Heterotopic Ossification (Ectopic Ossification) 01/2021 - 03/2011
4	Leukemia 10/2009 - 12/2005
3	Hypertension (High Blood Pressure) 01/2022 - 06/2014
2	Carcinogenesis 10/2022 - 09/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 02/2014
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2018 - 11/2017
2	Hypoxia (Hypoxemia) 05/2007 - 07/2002
1	Medulloblastoma 10/2022
1	Ovarian Neoplasms (Ovarian Cancer) 06/2022
1	Bone Diseases (Bone Disease) 06/2022
1	Pseudohypoaldosteronism 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Soft Tissue Injuries (Soft Tissue Injury) 01/2021
1	Atherosclerosis 01/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Rare Diseases (Rare Disease) 12/2019
1	Pulmonary Arterial Hypertension 12/2019
1	Drug-Related Side Effects and Adverse Reactions 12/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Acute Lung Injury 01/2018
1	Inflammation (Inflammations) 11/2015
1	Parkinson Disease (Parkinson's Disease) 02/2014
1	Colorectal Neoplasms (Colorectal Cancer) 10/2013
1	Progeria (Hutchinson Gilford Syndrome) 03/2013
1	Laminopathies 03/2013
1	Premature Aging 03/2013
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2012
1	Disease Progression 03/2011
1	Lymphoma (Lymphomas) 10/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2007
1	Hematologic Neoplasms (Hematological Malignancy) 07/2007

Drug/Important Bio-Agent (IBA)

16	Phosphotransferases (Kinase)IBA 06/2022 - 12/2007
6	dipinacoline glutamateIBA 01/2021 - 10/2014
6	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021 - 10/2012
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2012
5	Bone Morphogenetic Protein ReceptorsIBA 01/2021 - 01/2013
4	UbiquitinIBA 10/2022 - 05/2007
4	Pharmaceutical PreparationsIBA 02/2021 - 02/2014
4	Type I Bone Morphogenetic Protein ReceptorsIBA 11/2019 - 06/2013
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 10/2009
2	Ligases (Synthetase)IBA 10/2022 - 01/2019
2	saracatinibIBA 06/2022 - 01/2021
2	Tacrolimus Binding Protein 1A (FKBP12)IBA 01/2021 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 09/2010
2	CollagenIBA 01/2019 - 05/2007
2	Therapeutic UsesIBA 01/2016 - 11/2015
2	Serine (L-Serine)FDA Link 06/2013 - 03/2011
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2013 - 03/2011
2	proto-oncogene proteins pimIBA 07/2007 - 12/2005
2	CytokinesIBA 12/2005 - 12/2005
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Proline (L-Proline)FDA Link 01/2022
1	tacrolimus binding protein 1BIBA 01/2021
1	Discoidin Domain ReceptorsIBA 01/2021
1	Histones (Histone)IBA 01/2020
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	Proteolysis Targeting ChimeraIBA 12/2019
1	activin AIBA 11/2019
1	Discoidin Domain Receptor 1IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 11/2017
1	tetraethylpyrazine (TEP)IBA 11/2017
1	dabrafenibIBA 01/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	rebastinibIBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 06/2014
1	tyrosine receptor (receptor, tyrosine)IBA 06/2014
1	ponatinibIBA 06/2014
1	Protein Isoforms (Isoforms)IBA 06/2014
1	Kelch-Like ECH-Associated Protein 1IBA 02/2014
1	omipalisibIBA 10/2013
1	LigandsIBA 06/2013
1	Peptides (Polypeptides)IBA 03/2013
1	ZincIBA 03/2013
1	LaminsIBA 03/2013
1	Metalloproteases (Metalloproteinases)IBA 03/2013
1	LDN-212854IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 11/2012
1	Casein Kinase II (Casein Kinase 2)IBA 09/2010
1	K00135IBA 07/2007
1	Hydroxyproline (4 Hydroxyproline)IBA 05/2007
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 12/2005
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2002
1	CobaltIBA 07/2002
1	Oxygen (Dioxygen)IBA 07/2002
1	AsparagineIBA 07/2002

Therapy/Procedure

5	Therapeutics 10/2022 - 09/2010
1	Immunotherapy 01/2016